MX337365B - Composiciones nasales de vitamina b-12. - Google Patents

Composiciones nasales de vitamina b-12.

Info

Publication number
MX337365B
MX337365B MX2013004846A MX2013004846A MX337365B MX 337365 B MX337365 B MX 337365B MX 2013004846 A MX2013004846 A MX 2013004846A MX 2013004846 A MX2013004846 A MX 2013004846A MX 337365 B MX337365 B MX 337365B
Authority
MX
Mexico
Prior art keywords
vitamin
deficiency
nasal compositions
factors
methylcobalamin
Prior art date
Application number
MX2013004846A
Other languages
English (en)
Other versions
MX2013004846A (es
Inventor
Ketan R Patel
Milan R Patel
Prakashchandra J Shah
Original Assignee
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troikaa Pharmaceuticals Ltd filed Critical Troikaa Pharmaceuticals Ltd
Publication of MX2013004846A publication Critical patent/MX2013004846A/es
Publication of MX337365B publication Critical patent/MX337365B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

La deficiencia de vitamin B-12 es muy común entre la población. Las causas principales de la deficiencia de vitamin B-12 incluyen falta de factores intrínsecos y otros factores intestinales (por ejemplo, mala absorción), trastornos genéticos raros y toma inadecuada. La presente invención se relaciona con formulaciones intranasales de derivados de vitamin B tales como metilcobalamina. Cianocobalamina, que suministran absorción transnasal mejorada.
MX2013004846A 2010-10-29 2011-10-28 Composiciones nasales de vitamina b-12. MX337365B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2169MU2010 2010-10-29
PCT/IB2011/002546 WO2012056299A1 (en) 2010-10-29 2011-10-28 Nasal compositions of vitamin b12

Publications (2)

Publication Number Publication Date
MX2013004846A MX2013004846A (es) 2013-10-01
MX337365B true MX337365B (es) 2016-02-29

Family

ID=45350421

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004846A MX337365B (es) 2010-10-29 2011-10-28 Composiciones nasales de vitamina b-12.

Country Status (20)

Country Link
EP (1) EP2632430B1 (es)
JP (1) JP5843873B2 (es)
CN (1) CN103384513B (es)
AP (1) AP3814A (es)
AR (1) AR083658A1 (es)
BR (1) BR112013010049B1 (es)
CO (1) CO6801717A2 (es)
CU (1) CU24142B1 (es)
DK (1) DK2632430T3 (es)
EA (1) EA024475B1 (es)
ES (1) ES2686299T3 (es)
HU (1) HUE039349T2 (es)
MX (1) MX337365B (es)
MY (1) MY163106A (es)
PE (1) PE20131137A1 (es)
PL (1) PL2632430T3 (es)
PT (1) PT2632430T (es)
UA (1) UA111342C2 (es)
WO (1) WO2012056299A1 (es)
ZA (1) ZA201303024B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017281941A1 (en) * 2016-06-24 2019-02-07 Aegis Therapeutics Llc Compositions, devices, and methods for the treatment of alcohol use disorder
CA3044221A1 (en) 2016-11-18 2018-05-24 Opiant Pharmaceuticals, Inc. Intranasal nalmefene compositions and methods for the treatment of opioid overdose
WO2018142358A1 (en) * 2017-02-06 2018-08-09 Torrent Pharmaceuticals Ltd. Intranasal composition of methylcobalamin
US11504362B2 (en) 2017-06-09 2022-11-22 Exelixis, Inc. Liquid dosage forms to treat cancer
GB202013645D0 (en) 2020-08-31 2020-10-14 Innotesto Bvba Pharmacetical compositions for the nasal administration of a colbalamin compound

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT376879B (de) * 1982-10-27 1985-01-10 Gerot Pharmazeutika Verfahren zur herstellung einer injektionsloesung
US4724231A (en) 1985-04-16 1988-02-09 Nastech Pharmaceutical, Inc. Nasel compositions containing vitamin B12
ES2074396B1 (es) * 1993-03-24 1996-04-01 Farmalider Sa Sistema de administracion nasal de cianocobalamina (vitamina b12).
BE1007839A6 (nl) * 1993-12-20 1995-10-31 Merkus Franciscus W H M Prof Farmaceutische compositie voor de nasale toediening van hydroxocobalamine.
US7229636B1 (en) * 2003-03-04 2007-06-12 Nastech Pharmaceutical Company Inc. Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
ES2356242T3 (es) * 2003-05-07 2011-04-06 EISAI R&D MANAGEMENT CO., LTD. Preparación liofilizada conteniendo metilcobalamina y procedimiento de producción de esta preparación.
US20070111964A1 (en) * 2005-08-17 2007-05-17 Fleming And Company, Pharmaceuticals Vitamin B12 nasal spray and method of use
CN101600729A (zh) * 2006-06-23 2009-12-09 帕尔医疗公司 用于鼻内递送的氰钴胺低粘度水性制剂
US20090012039A1 (en) * 2007-03-16 2009-01-08 Stan Kurtz Use of methylcobalamin nasal spray to treat disorders
DE102007012644A1 (de) * 2007-03-16 2008-09-18 Bayer Healthcare Ag Stabilisierung von Vitamin B12

Also Published As

Publication number Publication date
DK2632430T3 (en) 2018-09-17
MX2013004846A (es) 2013-10-01
UA111342C2 (uk) 2016-04-25
ZA201303024B (en) 2014-01-29
EA201390623A1 (ru) 2013-09-30
PE20131137A1 (es) 2013-10-03
WO2012056299A1 (en) 2012-05-03
MY163106A (en) 2017-08-15
JP2013540805A (ja) 2013-11-07
BR112013010049A2 (pt) 2018-01-09
CO6801717A2 (es) 2013-11-29
ES2686299T3 (es) 2018-10-17
AP3814A (en) 2016-09-30
BR112013010049B1 (pt) 2021-07-13
EA024475B1 (ru) 2016-09-30
PT2632430T (pt) 2018-10-19
CU20130062A7 (es) 2013-10-29
HUE039349T2 (hu) 2018-12-28
PL2632430T3 (pl) 2018-11-30
JP5843873B2 (ja) 2016-01-13
CU24142B1 (es) 2015-12-23
AP2013006837A0 (en) 2013-04-30
CN103384513A (zh) 2013-11-06
CN103384513B (zh) 2016-01-13
AR083658A1 (es) 2013-03-13
EP2632430A1 (en) 2013-09-04
EP2632430B1 (en) 2018-06-06

Similar Documents

Publication Publication Date Title
IN2014MN00862A (es)
BR112012020693A8 (pt) Derivados de ciclobutano e metilciclobutano como inibidores de janus quinase e composição que os compreende
MX2014003889A (es) Compuestos antivirales.
MX337365B (es) Composiciones nasales de vitamina b-12.
MX2018013216A (es) Composiciones y metodos para inhibir la expresion del gen de proteasa transmembrana, serina 6 (tmprss6).
UA103915C2 (ru) Твердая лекарственная форма, которая содержит линаглиптин и ингибитор sglt2, и ее применение
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
IN2014DN08481A (es)
MX2012010434A (es) Compuestos y composiciones novedosas para atacar a las celulas madre del cancer.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
BR112012032248A2 (pt) composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
MX2013013649A (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
MX2009005938A (es) 6-oxo-1,6-dihidro-pirimidin-2-ilos en el tratamiento de enfermedades proliferativas.
MX351818B (es) Compuestos antivirales.
CA2843611C (en) Compositions and methods for reducing the incidence of equine digestive disorders
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
TR200908237A2 (tr) Kalsiyum ve D vitamini içeren farmasötik bileşimler.
MX2013013436A (es) Derivados de indol sustituidos para el tratamiento de transtornos inmunologicos.
ECSP13012977A (es) Composiciones y métodos para separar, caracterizar y administrar selenoglicoproteínas solubles
MX2012003230A (es) Composiciones farmaceuticas de rapamicina.
BR112012007418A2 (pt) Composições nutricionais incluindo teanina e nucleotídeos exógenos.
UA109889C2 (xx) Антиоксидантний засіб
GB2509470A (en) Pharmaceutical compositions of antihypertensives

Legal Events

Date Code Title Description
FG Grant or registration